Document is current
Any future updates will be listed below
-
Authors
Sriram, Sandhya
Yuan, Chengxiang
Chakraborty, Smarajit
Tay, Winson
Park, Min
Shabbir, Asim
Toh, Sue-Anne
Han, Weiping
Sugii, Shigeki https://orcid.org/0000-0002-2537-9534
-
Funding
Funding for this research was provided by:
A*STAR BMRC
Singapore-China Joint Grant Project (#1412424003)
A*STAR Joint Council Office (DPG #1334k00083)
National Medical Research Council
- License Information
-
More Information
Article History
Received: 5 December 2018
Revised: 28 March 2019
Accepted: 22 April 2019
First Online: 21 May 2019
Ethics approval and consent to participate
: Use of human patient-derived cells was conducted with informed consent obtained for each subject, approved by the National Healthcare Group Domain Specific Review Board, Singapore, and performed in accordance with its relevant regulations.
: Not applicable
: ShS is a co-founder of Celligenics Pte Ltd., which has not had any financial or scientific influence on this study. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
